Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Femasys Inc. (FEMY:NASDAQ), powered by AI.
Femasys Inc. is currently trading at $4.18. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Femasys Inc. on Alpha Lenz.
View Femasys Inc.'s valuation metrics on Alpha Lenz.
“Femasys Inc.'s ROE is -455.8%. Explore profitability and growth together.”
Ask for details →Femasys Inc. is a medical device company committed to advancing women's healthcare solutions. The company specializes in developing and commercializing minimally invasive technologies that address various aspects of female reproductive health. Its product portfolio includes innovative devices for fertility, contraception, and cancer diagnosis. Femasys Inc. has made significant strides in the medical device industry through products such as FemVue, a diagnostic tool for fertility assessment, and FemBloc, an investigational permanent birth control solution. The company plays a critical role in the healthcare sector by providing specialized tools that enhance diagnostic accuracy and improve patient outcomes. Headquartered in Atlanta, Georgia, Femasys Inc. collaborates with healthcare professionals and institutions to deliver cutting-edge solutions that meet the unique needs of women globally. Through its commitment to innovation and patient care, Femasys contributes significantly to the advancement of reproductive health and the broader medical device market.
“Femasys Inc.'s ROE is -455.8%. Explore profitability and growth together.”
Ask for details →Femasys Inc. (ticker: FEMY) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 69 employees.
The current price is $4.18 with a P/E ratio of -x and P/B of -x.
ROE is -455.80% and operating margin is -766.95%. Annual revenue is $2M.